GARY DUBIN
Medical Practice in Norristown, PA
License number
Pennsylvania MD038154E
Category
Medicine
Type
Medical Physician and Surgeon
Address
Address
Norristown, PA 19406
Professional information
Hpv-16 And-18 L1 Vlp Vaccine
US Patent:
2006025, Nov 9, 2006
Filed:
Dec 18, 2003
Appl. No.:
10/540099
Inventors:
Gary Dubin - King of Prussia PA, US
Bruce Innis - King of Prussia PA, US
Moncef Slaoui - King of Prussia PA, US
Martine Wettendorff - King of Prussia PA, US
Bruce Innis - King of Prussia PA, US
Moncef Slaoui - King of Prussia PA, US
Martine Wettendorff - King of Prussia PA, US
International Classification:
A61K 39/12
US Classification:
424204100
Abstract:
The invention relates to use of HPV 16 and HPV 18 VLPs to provide cross protection against infection and/or disease by other HPV types.
Assay
US Patent:
2005003, Feb 17, 2005
Filed:
Aug 6, 2002
Appl. No.:
10/485838
Inventors:
Brigitte Colau - Rixensart, BE
Gary Dubin - King of Prussia PA, US
Marie-Therese Martin - Rixensart, BE
Wim Quint - King of Prussia PA, US
Gary Dubin - King of Prussia PA, US
Marie-Therese Martin - Rixensart, BE
Wim Quint - King of Prussia PA, US
International Classification:
C12Q001/68, C12P019/34
US Classification:
435006000, 435091200
Abstract:
A process for identification of type-specific polynucleotide sequences in a sample, the process comprising the steps of (1) contacting polynucleotides from the sample, or derived from the sample, with a plurality of type-specific probes in the context of a solid support, and detection of any type-specific hybridisation; and (2) contacting polynucleotides in the sample, or derived from the sample, with type-specific primers for those types capable of being detected by the hybridisation step in step 1, but not so detected, in a type-specific amplification reaction.
Assay
US Patent:
2007003, Feb 8, 2007
Filed:
Oct 12, 2006
Appl. No.:
11/581251
Inventors:
Brigitte Desiree Colau - Rixensart, BE
Gary Dubin - King of Prussia PA, US
Marie-Therese Martin - Rixensart, BE
Wim Quint - Delft, NL
Leen-Jan Van Doorn - Delft, NL
Gary Dubin - King of Prussia PA, US
Marie-Therese Martin - Rixensart, BE
Wim Quint - Delft, NL
Leen-Jan Van Doorn - Delft, NL
International Classification:
C12Q 1/68, C12P 19/34, C12Q 1/70
US Classification:
435005000, 435006000, 435091200
Abstract:
A process for identification of type-specific polynucleotide sequences in a sample, the process comprising the steps of (1) contacting polynucleotides from the sample, or derived from the sample, with a plurality of type-specific probes in the context of a solid support, and detection of any type-specific hybridisation; and (2) contacting polynucleotides in the sample, or derived from the sample, with type-specific primers for those types capable of being detected by the hybridisation step in step 1, but not so detected, in a type-specific amplification reaction.
Vaccine
US Patent:
2005028, Dec 29, 2005
Filed:
Apr 26, 2005
Appl. No.:
11/114301
Inventors:
Gary Dubin - King of Prussia PA, US
Bruce Innis - King of Prussia PA, US
Moncef Slaoui - King of Prussia PA, US
Martine Cecile Wettendorff - Rixensart, BE
Bruce Innis - King of Prussia PA, US
Moncef Slaoui - King of Prussia PA, US
Martine Cecile Wettendorff - Rixensart, BE
International Classification:
A61K039/12
US Classification:
424186100
Abstract:
This invention pertains to methods for treating infections caused by human papillomaviruses. It has been determined that immunization with HPV16 and HPV 18 virus like particles provides cross-protection against other HPV types.
Vaccine
US Patent:
7858098, Dec 28, 2010
Filed:
Dec 16, 2005
Appl. No.:
11/367601
Inventors:
Gary Dubin - King of Prussia PA, US
Bruce Innis - King of Prussia PA, US
Moncef Mohammed Slaoui - King of Prussia PA, US
Martine Anne Cecile Wettendorff - Rixensart, BE
Bruce Innis - King of Prussia PA, US
Moncef Mohammed Slaoui - King of Prussia PA, US
Martine Anne Cecile Wettendorff - Rixensart, BE
Assignee:
GlaxoSmithKline Biologicals, s.a. - Rixensart
International Classification:
A61K 39/12, A61K 39/295
US Classification:
4242041
Abstract:
This invention pertains to methods for treating infections caused by human papillomaviruses. It has been determined that immunization with HPV16 and HPV 18 virus like particles provides cross-protection against other HPV types.